Contact

Jamie Lacey-Moreira, PressComm PR Principal & Founder

Are you ready to give your communications strategy a new perspective? The PressComm PR team works with life science and health care organizations, delivering a flexible, resource-leveraging communications program.

Please contact Jamie to let us know how we can help your organization:

Jamie Lacey-Moreira, Principal
PressComm PR, LLC
Ph: 410.299.3310
Email: jamielacey@presscommpr.com

News

July 11, 2019

Genomics leader Illumina is opening a new center at University of Maryland BioPark
It's the first East Coast location for the San Diego-based company. Here's how leaders say it can raise the profile for Baltimore's biotech community. A [Read More]
June 10, 2019

GlycoMimetics CEO Rachel King Featured in Article on Uproleselan
In Cancer, Boosting Chemotherapy while Reducing Toxic Side Effects is a Potential Breakthrough GlycoMimetics is conducting a pivotal Phase 3 trial in the US, Europe [Read More]
May 8, 2019

MaxCyte Progresses Phase I Clinical Trial of Lead mRNA-based Cell Therapy from its CARMA™ Platform
– No dose-limiting toxicities or safety concerns observed in first cohort of treated patients– Feasibility of streamlined, faster CAR therapy manufacturing [Read More]

PressComm

Contact

Contact

Site Links

Social

About PressComm PR